Watermark
  Back to Search Results

BGB-A317-LBL-007-202

Active, not recruiting

A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-LBL-007-202

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06010303

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20233227

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents